Lessons learned from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC)

Juan I. Martínez-Salamanca; Estefania Linares; Javier González; Roberto Bertini; Joaquín A. Carballido; Thomas Chromecki; Gaetano Ciancio; Sia Daneshmand; Christopher P. Evans; Paolo Gontero; Axel Haferkamp; Markus Hohenfellner; William C. Huang; Theresa M. Koppie; Viraj A. Master; Rayan Matloob; James M. McKiernan; Carrie M. Mlynarczyk; Francesco Montorsi; Hao G. Nguyen; Giacomo Novara; Sascha Pahernik; Juan Palou; Raj S. Pruthi; Krishna Ramaswamy; Oscar Rodriguez Faba; Paul Russo; Shahrokh F. Shariat; Martin Spahn; Carlo Terrone; Derya Tilki; Daniel Vergho; Eric M. Wallen; Evanguelos Xylinas; Richard Zigeuner; John A. Libertino

doi:10.1007/s11934-014-0404-7

Lessons learned from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC)

Juan I. Martínez-Salamanca, Estefania Linares, Javier González, Roberto Bertini, Joaquín A. Carballido, Thomas Chromecki, Gaetano Ciancio, Sia Daneshmand, Christopher P. Evans, Paolo Gontero, Axel Haferkamp, Markus Hohenfellner, William C. Huang, Theresa M. Koppie, Viraj A. Master, Rayan Matloob, James M. McKiernan, Carrie M. Mlynarczyk, Francesco Montorsi, Hao G. NguyenGiacomo Novara, Sascha Pahernik, Juan Palou, Raj S. Pruthi, Krishna Ramaswamy, Oscar Rodriguez Faba, Paul Russo, Shahrokh F. Shariat, Martin Spahn, Carlo Terrone, Derya Tilki, Daniel Vergho, Eric M. Wallen, Evanguelos Xylinas, Richard Zigeuner, John A. Libertino

Risultato della ricerca: Contributo su rivista › Articolo in rivista › peer review

Abstract

Renal cell carcinoma (RCC) extension into the renal vein or the inferior vena cava occurs in 4 %-10 % of all kidney cancer cases. This entity shows a wide range of different clinical and surgical scenarios, making natural history and oncological outcomes variable and poorly characterized. Infrequency and variability make it necessary to share the experience from different institutions to properly analyze surgical outcomes in this setting. The International Renal Cell Carcinoma-Venous Tumor Thrombus Consortium was created to answer the questions generated by competing results from different retrospective studies in RCC with venous extension on current controversial topics. The aim of this article is to summarize the experience gained from the analysis of the world's largest cohort of patients in this unique setting to date.

Lingua originale	Inglese
Numero di articolo	404
Rivista	Current Urology Reports
Volume	15
Numero di pubblicazione	5
DOI	https://doi.org/10.1007/s11934-014-0404-7
Stato di pubblicazione	Pubblicato - mag 2014
Pubblicato esternamente	Sì

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.1007/s11934-014-0404-7

Altri file e collegamenti

Link to publication in Scopus

Cita questo

Martínez-Salamanca, J. I., Linares, E., González, J., Bertini, R., Carballido, J. A., Chromecki, T., Ciancio, G., Daneshmand, S., Evans, C. P., Gontero, P., Haferkamp, A., Hohenfellner, M., Huang, W. C., Koppie, T. M., Master, V. A., Matloob, R., McKiernan, J. M., Mlynarczyk, C. M., Montorsi, F., ... Libertino, J. A. (2014). Lessons learned from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC). Current Urology Reports, 15(5), Articolo 404. https://doi.org/10.1007/s11934-014-0404-7

@article{ab896e5a594d46a592e497c0cca8939c,

title = "Lessons learned from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC)",

abstract = "Renal cell carcinoma (RCC) extension into the renal vein or the inferior vena cava occurs in 4 %-10 % of all kidney cancer cases. This entity shows a wide range of different clinical and surgical scenarios, making natural history and oncological outcomes variable and poorly characterized. Infrequency and variability make it necessary to share the experience from different institutions to properly analyze surgical outcomes in this setting. The International Renal Cell Carcinoma-Venous Tumor Thrombus Consortium was created to answer the questions generated by competing results from different retrospective studies in RCC with venous extension on current controversial topics. The aim of this article is to summarize the experience gained from the analysis of the world's largest cohort of patients in this unique setting to date.",

keywords = "Cohort, Consortium, Inferior vena cava, Multi-institutional, Radical nephrectomy, Renal cell carcinoma, Thrombectomy, Tumor thrombus",

author = "Mart{\'i}nez-Salamanca, {Juan I.} and Estefania Linares and Javier Gonz{\'a}lez and Roberto Bertini and Carballido, {Joaqu{\'i}n A.} and Thomas Chromecki and Gaetano Ciancio and Sia Daneshmand and Evans, {Christopher P.} and Paolo Gontero and Axel Haferkamp and Markus Hohenfellner and Huang, {William C.} and Koppie, {Theresa M.} and Master, {Viraj A.} and Rayan Matloob and McKiernan, {James M.} and Mlynarczyk, {Carrie M.} and Francesco Montorsi and Nguyen, {Hao G.} and Giacomo Novara and Sascha Pahernik and Juan Palou and Pruthi, {Raj S.} and Krishna Ramaswamy and Faba, {Oscar Rodriguez} and Paul Russo and Shariat, {Shahrokh F.} and Martin Spahn and Carlo Terrone and Derya Tilki and Daniel Vergho and Wallen, {Eric M.} and Evanguelos Xylinas and Richard Zigeuner and Libertino, {John A.}",

year = "2014",

month = may,

doi = "10.1007/s11934-014-0404-7",

language = "English",

volume = "15",

journal = "Current Urology Reports",

issn = "1527-2737",

publisher = "Current Science, Inc.",

number = "5",

}

Martínez-Salamanca, JI, Linares, E, González, J, Bertini, R, Carballido, JA, Chromecki, T, Ciancio, G, Daneshmand, S, Evans, CP, Gontero, P, Haferkamp, A, Hohenfellner, M, Huang, WC, Koppie, TM, Master, VA, Matloob, R, McKiernan, JM, Mlynarczyk, CM, Montorsi, F, Nguyen, HG, Novara, G, Pahernik, S, Palou, J, Pruthi, RS, Ramaswamy, K, Faba, OR, Russo, P, Shariat, SF, Spahn, M, Terrone, C, Tilki, D, Vergho, D, Wallen, EM, Xylinas, E, Zigeuner, R & Libertino, JA 2014, 'Lessons learned from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC)', Current Urology Reports, vol. 15, n. 5, 404. https://doi.org/10.1007/s11934-014-0404-7

TY - JOUR

T1 - Lessons learned from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC)

AU - Martínez-Salamanca, Juan I.

AU - Linares, Estefania

AU - González, Javier

AU - Bertini, Roberto

AU - Carballido, Joaquín A.

AU - Chromecki, Thomas

AU - Ciancio, Gaetano

AU - Daneshmand, Sia

AU - Evans, Christopher P.

AU - Gontero, Paolo

AU - Haferkamp, Axel

AU - Hohenfellner, Markus

AU - Huang, William C.

AU - Koppie, Theresa M.

AU - Master, Viraj A.

AU - Matloob, Rayan

AU - McKiernan, James M.

AU - Mlynarczyk, Carrie M.

AU - Montorsi, Francesco

AU - Nguyen, Hao G.

AU - Novara, Giacomo

AU - Pahernik, Sascha

AU - Palou, Juan

AU - Pruthi, Raj S.

AU - Ramaswamy, Krishna

AU - Faba, Oscar Rodriguez

AU - Russo, Paul

AU - Shariat, Shahrokh F.

AU - Spahn, Martin

AU - Terrone, Carlo

AU - Tilki, Derya

AU - Vergho, Daniel

AU - Wallen, Eric M.

AU - Xylinas, Evanguelos

AU - Zigeuner, Richard

AU - Libertino, John A.

PY - 2014/5

Y1 - 2014/5

N2 - Renal cell carcinoma (RCC) extension into the renal vein or the inferior vena cava occurs in 4 %-10 % of all kidney cancer cases. This entity shows a wide range of different clinical and surgical scenarios, making natural history and oncological outcomes variable and poorly characterized. Infrequency and variability make it necessary to share the experience from different institutions to properly analyze surgical outcomes in this setting. The International Renal Cell Carcinoma-Venous Tumor Thrombus Consortium was created to answer the questions generated by competing results from different retrospective studies in RCC with venous extension on current controversial topics. The aim of this article is to summarize the experience gained from the analysis of the world's largest cohort of patients in this unique setting to date.

AB - Renal cell carcinoma (RCC) extension into the renal vein or the inferior vena cava occurs in 4 %-10 % of all kidney cancer cases. This entity shows a wide range of different clinical and surgical scenarios, making natural history and oncological outcomes variable and poorly characterized. Infrequency and variability make it necessary to share the experience from different institutions to properly analyze surgical outcomes in this setting. The International Renal Cell Carcinoma-Venous Tumor Thrombus Consortium was created to answer the questions generated by competing results from different retrospective studies in RCC with venous extension on current controversial topics. The aim of this article is to summarize the experience gained from the analysis of the world's largest cohort of patients in this unique setting to date.

KW - Cohort

KW - Consortium

KW - Inferior vena cava

KW - Multi-institutional

KW - Radical nephrectomy

KW - Renal cell carcinoma

KW - Thrombectomy

KW - Tumor thrombus

UR - http://www.scopus.com/inward/record.url?scp=84896690101&partnerID=8YFLogxK

U2 - 10.1007/s11934-014-0404-7

DO - 10.1007/s11934-014-0404-7

M3 - Article

SN - 1527-2737

VL - 15

JO - Current Urology Reports

JF - Current Urology Reports

IS - 5

M1 - 404

ER -

Lessons learned from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC)

Abstract

OSS delle Nazioni Unite

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo